Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD
Clinical trial NCT05612035 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05612035
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-16
- Primary completion
- 2026-04-09
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.